Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors

Flavia Morales-VásquezRocío Castillo-SánchezMaría J. GómoraMiguel Ángel AlmarazE. PederneraDelia Pérez‐MontielElizabeth RendónHoracio Noé López-BasaveEdgar Román-BasaureSergio A. Cuevas‐Covarrubias2026-03-222026-03-22202010.1186/s13048-020-00676-xhttps://doi.org/10.1186/s13048-020-00676-xhttps://andeanlibrary.org/handle/123456789/45799Citaciones: 15The presence of MMP-2 in the stroma of the tumor was a protective factor while the presence of MMP-2 in the epithelium indicated an adverse prognosis. The presence of AR associated with MMP-2 in the tumor cells was a risk factor for overall survival in epithelial ovarian cancer.enMatrix metalloproteinaseAndrogen receptorReceptorMedicineReproductive medicineCancer researchInternal medicineEndocrinologyExpression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumorsarticle